Asia Pacific Spinal Cord Stimulation Devices Market Estimated to Grow with a CAGR of 9.3%, 2019-2025 - ResearchAndMarkets.com

The "Asia Pacific Spinal Cord Stimulation Devices Market 2019-2025)" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific Spinal Cord Stimulation Devices Market is expected to witness market growth of 9.3% CAGR during the forecast period (2019-2025).

The growing geriatric population and favorable reimbursement and insurance approval measures are key variables influencing the rise of this industry. Strict governmental approvals and high device costs, however, will hamper this market's growth. Besides, the introduction of new methods in minimally invasive surgery will generate profitable possibilities for core participants in the market.

Stimulation of the spinal cord has been in therapy use for almost 50 years. Specifically, the understanding of how to use it properly and the technology's sophistication has significantly progressed. High quality, randomized, comparative clinical trials in the treatment of clients with refractory neuropathic pain have shown unequivocal clinical and price-effectiveness. Stimulation of the spinal cord can also be used in ischaemic pain syndromes, like angina pectoris, chronic critical limb ischemia, and other syndromes of visceral pain including chronic painful bladder syndrome, pancreatitis, and abdominal pain.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 Asia Pacific Spinal Cord Stimulation Devices Market, by Product

1.4.2 Asia Pacific Spinal Cord Stimulation Devices Market, by Application

1.4.3 Asia Pacific Spinal Cord Stimulation Devices Market, by Country

1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. Asia Pacific Spinal Cord Stimulation Devices Market by Applications

3.1 Asia Pacific Complex Regional Pain Syndrome Market by Country

3.2 Asia Pacific Unsuccessful Disk Surgery Market by Country

3.3 Asia Pacific Failed Back Syndrome Market by Country

3.4 Asia Pacific Degenerative Disk Disease Market by Country

3.5 Asia Pacific Other Applications Market by Country

Chapter 4. Asia Pacific Spinal Cord Stimulation Devices Market by Product

4.1 Asia Pacific Rechargeable Market by Country

4.2 Asia Pacific Non-Rechargeable Market by Country

Chapter 5. Asia Pacific Spinal Cord Stimulation Devices Market by Country

5.1 China Spinal Cord Stimulation Devices Market

5.1.1 China Spinal Cord Stimulation Devices Market by Applications

5.1.2 China Spinal Cord Stimulation Devices Market by Product

5.2 India Spinal Cord Stimulation Devices Market

5.3 Japan Spinal Cord Stimulation Devices Market

5.4 Australia Spinal Cord Stimulation Devices Market

5.5 South Korea Spinal Cord Stimulation Devices Market

5.6 Singapore Spinal Cord Stimulation Devices Market

5.7 Rest of Asia Pacific Spinal Cord Stimulation Devices Market

Chapter 6. Company Profiles

6.1 Boston Scientific Corporation

6.1.1 Company Overview

6.1.2 Financial Analysis

6.1.3 Segmental and Regional Analysis

6.1.4 Research & Development Expense

6.1.1 Recent strategies and developments:

6.1.1.1 Product launches:

6.1.1.2 Acquisition and mergers:

6.1.1.3 Collaborations, partnerships and agreements:

6.2 Medtronic PLC

6.3 Abbott Laboratories (St. Jude Medical, Inc.)

6.4 Neurosigma, Inc.

6.5 Nevro Corporation

6.6 Synapse BioMedical, Inc.

6.7 Integer Holdings Corporation

6.8 Stimwave Technologies, Inc.

6.9 Nuvectra Corporation

6.10 Saluda Medical Pty Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/sfv4tf

View source version on businesswire.com: https://www.businesswire.com/news/home/20191118005755/en/